Page last updated: 2024-10-21

vanilmandelic acid and Neural Tube Defects

vanilmandelic acid has been researched along with Neural Tube Defects in 1 studies

Vanilmandelic Acid: A 3-O-methyl ether of 3,4-dihydroxymandelic acid. It is an end-stage metabolite of CATECHOLAMINES; EPINEPHRINE; and NOREPINEPHRINE.
vanillylmandelic acid : An aromatic ether that is the 3-O-methyl ether of 3,4-dihydroxymandelic acid.

Neural Tube Defects: Congenital malformations of the central nervous system and adjacent structures related to defective neural tube closure during the first trimester of pregnancy generally occurring between days 18-29 of gestation. Ectodermal and mesodermal malformations (mainly involving the skull and vertebrae) may occur as a result of defects of neural tube closure. (From Joynt, Clinical Neurology, 1992, Ch55, pp31-41)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lagercrantz, H1
Sjöquist, B1

Other Studies

1 other study available for vanilmandelic acid and Neural Tube Defects

ArticleYear
Catecholamine metabolites in amniotic fluid from fetuses with neural tube defects.
    Prenatal diagnosis, 1981, Volume: 1, Issue:2

    Topics: Amniotic Fluid; Catecholamines; Chromatography, Gas; Female; Humans; Mass Spectrometry; Methoxyhydro

1981